Variant · Snv
MICA NM_001177519.3(MICA):c.325+1G>A
CI-VAR-00306242Explore in graph →NM_001177519.3:c.325+1G>AClinVar 2656400 rs181430930
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-14
- Retrieved
- Sep 15, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260915-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 2656400 | Likely benign | criteria provided, single submitter | 1 | Chronic lymphocytic leukemia/small lymphocytic lymphoma; Malignant lymphoma, large B-cell, diffuse; Thyroid cancer, nonmedullary, 1; Adrenocortical carcinoma, hereditary; Uterine corpus endometrial carcinoma; Clear cell carcinoma of kidney; Uterine carcinosarcoma; Malignant tumor of urinary bladder; Lung cancer; Familial cancer of breast; Colon adenocarcinoma; Sarcoma; Gastric cancer; Lymphoma; Ovarian serous cystadenocarcinoma | germline | 2 | Sep 01, 2023 | clinvar |